Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Tesaro, Inc. (TSRO)

   0 (0%) 06-28 18:07
Open: Pre. Close:
High: Low:
Volume: 0 Market Cap: 0(M)

Technical analysis

as of: 2023-05-31 11:19:52 AM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 6.23     One year: 7.13
Support: Support1: 4.09    Support2: 3.4
Resistance: Resistance1: 5.33    Resistance2: 6.11
Pivot: 5.32
Moving Average: MA(5): 4.84     MA(20): 5.28
MA(100): 5.73     MA(250): 5.98
MACD: MACD(12,26): -0.1     Signal(9): 0
Stochastic oscillator: %K(14,3): 2.4     %D(3): 7.5
RSI: RSI(14): 36.6
52-week: High: 8.72  Low: 3.32
Average Vol(K): 3-Month: 485 (K)  10-Days: 386 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ STRO ] has closed above bottom band by 0.3%. Bollinger Bands are 20% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.98 - 5.03 5.03 - 5.06
Low: 4.46 - 4.52 4.52 - 4.56
Close: 4.54 - 4.64 4.64 - 4.7

Company Description

Headline News

Wed, 05 May 2021
Agreement to acquire TESARO - GSK

Mon, 03 Dec 2018
Tesaro Stock Soars After Announcing Agreeing to Be Bought By Glaxosmithkline - Warrior Trading News

Mon, 03 Dec 2018
GSK reaches agreement to acquire TESARO, an oncology focused ... - GlobeNewswire

Mon, 03 Dec 2018
GlaxoSmithKline to acquire Tesaro for $4.16 billion - MarketWatch

Mon, 22 Oct 2018
3 Biotech Stocks Poised to Rise by 15% or More - Investopedia

Wed, 10 Oct 2018
Biotech Gearing Up for a Pullback? - Investopedia

Financial Analysis

Price to Book Value: Underperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  YHD
Shares Out. 60 (M)
Shares Float 46 (M)
% Held by Insiders 5.5 (%)
% Held by Institutions 87.4 (%)
Shares Short 2,970 (K)
Shares Short P.Month 2,800 (K)

Stock Financials

EPS -2.41
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.07
Profit Margin (%) -174.6
Operating Margin (%) -177.2
Return on Assets (ttm) -25
Return on Equity (ttm) -64.2
Qtrly Rev. Growth 114.9
Gross Profit (p.s.) 0
Sales Per Share 1.23
EBITDA (p.s.) -2.1
Qtrly Earnings Growth 0
Operating Cash Flow -22 (M)
Levered Free Cash Flow -52 (M)

Stock Valuations

PE Ratio -1.9
PEG Ratio 0
Price to Book value 1.47
Price to Sales 3.66
Price to Cash Flow -12.32

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.